SEC Form 4 · accession 0000899243-16-019891
Coherus Oncology, Inc. · CHRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan C. Herman
Officer — Chief Scientific Officer
Period of report
May 11, 2016
Accepted (ET)
May 13, 2016 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001512762
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value | holding | — | — | — | 206,615 | D | ||
| Common Stock, $0.0001 par valueF1 | holding | — | — | — | 300,164 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $17.17 | May 11, 2016 | A | 69,236 | D | — | May 11, 2026 | Common Stock | 69,236 | 69,236 | D |
Explanation of responses
- F1These shares are held by the Herman Trust, dated March 16, 2001, of which Reporting Person is a co trustee.
- F2The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from May 6, 2016, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.